Form D · Biotechnology
Keraplast Technologies Management, LLC
San Antonio, TX · CIK 0001466110
Offering snapshot reported Jun 19, 2009 · SEC filing
- Reported sold
- Yet to sell Offering amount: $2.5M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 19, 2009 | Initial | Yet to sell | No comparison | 14 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-132098
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| NA | None |
Source: Form D, filed Jun 19, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Norman P. Blake | Director |
| Michael Espensen | Director |
| Tim Herring | Director, Executive |
| Greg A. Kozmetsky | Director |
| Charles La Maistre | Director |
| William F. Shea | Director |
| Robert A, Smith | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
19210 Huebner Road Suite 200
San Antonio, TX, 78258-3103
San Antonio, TX, 78258-3103